The linked FDA record set links one premarket notification to Paragon 28, Inc.: K261120, received April 3, 2026 and decided October 7, 2026 as Substantially Equivalent. The clearance letter identifies the trade name APEX 3D S Diamond Tibia and places it in regulation 21 CFR 888.3110, Ankle Joint Metal/Polymer Semi-Constrained Cemented Prosthesis, Class II, product code HSN. The same letter states the device has the same intended use as the predicate device and incorporates similar technological characteristics. The applicant address on the filing is 14445 Grasslands Drive, Englewood, Colorado 80112, and the correspondence is addressed to Edward Wells-Spicer, Senior Regulatory Affairs Specialist. [1][2][3]
The K261120 clearance and its scope
K261120 was submitted as a Traditional 510(k), reviewed by the Orthopedic panel, and not reviewed by a third party. The FDA record lists the decision as Substantially Equivalent with a decision date of October 7, 2026, and the premarket notification page shows the same received and decision dates. The submission carried a summary rather than only a statement, and no predetermined change control plan was authorized. The device is classified as Class II under product code HSN with the orthopedic medical specialty. [1][2][3]
The clearance letter describes the device as an ankle joint metal/polymer semi-constrained cemented prosthesis and states that it has the same intended use as the predicate device and incorporates similar technological characteristics. The letter is dated October 7, 2026 and references a submission dated and received September 18, 2026, while the FDA database entries record the original receipt as April 3, 2026. Both dates appear in the public documents and are reported as recorded rather than reconciled. [1][2][3]
APEX 3D S and APEX 3D system descriptions
Paragon 28's own surgical technique guide for the APEX 3D S Stemmed Tibia describes a fixed bearing total ankle replacement system made up of a tibial component with additional proximal fixation, a talar component, and a Vitamin E Ultra-High Molecular Weight Polyethylene component. The guide states that implants are available in varying sizes and design configurations intended for both primary and revision applications. The cleared K261120 device name, APEX 3D S Diamond Tibia, corresponds to the tibial side of that named system family. [5][1]
Separate Paragon 28 technique guides for the APEX 3D Total Ankle Replacement System describe a fixed bearing device with a tibial component, a talar component and a Vitamin E Ultra-High Molecular Weight Polyethylene component, again offered in varying sizes and configurations for primary and revision applications. Those guides list a design team including Mark Dalton, MD, Jeffrey Christensen, DPM, Michael Houghton, MD and Mark Myerson, MD. The guides are published by Paragon 28, Inc. at its Englewood, Colorado address and state that federal law restricts the device to sale and use by, or on the order of, a physician. [6][7][8][9]
Applicant identity and record boundaries
Paragon 28, Inc. is the applicant named on K261120, and the FDA letter and database entry give its address as 14445 Grasslands Drive, Englewood, Colorado 80112. That address is a filing and correspondence address in the sources; it is not presented here as a verified corporate headquarters. No parent company, brand owner, distributor relationship or website is confirmed by the public information, and the technique guides identify Paragon 28, Inc. as the party that patents, designs and exclusively distributes the described systems. [1][2][5][6]
The linked collection contains one 510(k) record, and its decision count is one Substantially Equivalent decision; the explicitly smaller record sample likewise contains that single entry. These are counts of the supplied filings as of the snapshot date, not measures of total company sales, total portfolio size or safety performance. No recall records appear in the supplied sample, and the absence of recalls in that sample does not establish a safety record. [1][3]







